Watchlist Price Alert

Spyre Therapeutics Inc. (SYRE)

NASDAQ: SYRE · Real-Time Price · USD

15.06

-0.01 (-0.07%)

At close: May 23, 2025, 3:59 PM

15.01

-0.33%

After-hours: May 23, 2025, 04:20 PM EDT

Spyre Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	886K	2.33M	18.74M	n/a	n/a	3.89M	5.21M	4.63M
Cost of Revenue	n/a	964K	1.96M	2M	1.62M	901K	n/a	n/a	n/a
Gross Profit	n/a	-78K	365K	16.74M	-1.62M	-901K	3.89M	5.21M	4.63M
Operating Income	-208.57M	-242.3M	-84.78M	-65.65M	-81.48M	-80.33M	-45.46M	-27.68M	-21.91M
Interest Income	21.31M	6.15M	837K	111K	593K	2.14M	1.17M	482K	244K
Pretax Income	-207.97M	-338.82M	-83.95M	-65.66M	-80.89M	-78.25M	-44.35M	-27.24M	-21.7M
Net Income	-208.02M	-338.79M	-83.81M	-65.8M	-80.89M	-78.25M	-44.35M	-27.24M	-21.7M
Selling & General & Admin	45.78M	39.95M	28.53M	27.32M	21.84M	14.83M	12.34M	9.82M	8.26M
Research & Development	162.79M	89.5M	58.58M	57.07M	59.64M	64.6M	36.72M	22.82M	18.14M
Other Expenses	n/a	113.74M	-7K	-122K	-5K	n/a	n/a	n/a	n/a
Operating Expenses	208.57M	243.19M	87.11M	84.39M	81.48M	79.43M	49.06M	32.63M	26.4M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	243.19M	87.11M	84.39M	81.48M	80.33M	49.35M	32.88M	26.53M
Income Tax Expense	51K	-26K	-136K	141K	-593K	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	374.39M	7.34M	3.37M	2.63M	2.13M	1.28M	832.9K	605.13K	391.67K
Shares Outstanding (Diluted)	374.39M	7.34M	3.37M	2.63M	2.13M	1.28M	832.9K	605.13K	391.67K
EPS (Basic)	-0.56	-46.15	-24.86	-25.02	-37.89	-61.23	-53.25	-45.01	-55.4
EPS (Diluted)	-0.56	-46.15	-24.86	-25.02	-37.89	-61.23	-53.25	-45.01	-55.4
EBITDA	-207.97M	-127.82M	-83.21M	-63.66M	-79.27M	-77.35M	-45.17M	-27.43M	-21.77M
EBIT	-207.97M	-128.56M	-84.78M	-65.65M	-80.89M	-78.25M	-45.46M	-27.68M	-21.91M
Depreciation & Amortization	n/a	964K	1.96M	2M	1.62M	901K	293K	249K	132K